Assessment of pancreatitis associated with tocilizumab use using the United States Food and Drug Administration Adverse Event Reporting System database

Tocilizumab (TCZ) is used to treat rheumatoid arthritis and other systemic inflammatory disorders. There is some evidence suggesting the occurrence of pancreatitis following TCZ use. We aimed to determine the reporting of pancreatitis following TCZ use in comparison with other drugs using the United...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamath, Ashwin, Acharya, Sahana D., Rao, Rashmi R., Ullal, Sheetal D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458491/
https://www.ncbi.nlm.nih.gov/pubmed/34552181
http://dx.doi.org/10.1038/s41598-021-98325-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458491/
https://www.ncbi.nlm.nih.gov/pubmed/34552181
http://dx.doi.org/10.1038/s41598-021-98325-w

Ejemplares similares